Upon incubation with 9F7-F11, we observed BID cleavage and BIM expression also in DU145 prostate cancer cells, which are BAX-deficient [42] but express BAK that could replace BAX to induce caspase-9 activation. Here, BCL2L11 is linked to prostate cancer.